Correction: The CDK7 inhibitor CT7001 (Samuraciclib) targets proliferation pathways to inhibit advanced prostate cancer

British Journal of Cancer, Published online: 14 February 2024; doi:10.1038/s41416-024-02606-wCorrection: The CDK7 inhibitor CT7001 (Samuraciclib) targets proliferation pathways to inhibit advanced prostate cancer

Source: British Journal of Cancer - February 14, 2024 Category: Cancer & Oncology Authors: Theodora A. Constantin Anabel Varela-Carver Kyle K. Greenland Gilberto Serrano de Almeida Ellen Olden Lucy Penfold Simon Ang Alice Ormrod Damien A. Leach Chun-Fui Lai Edward K. Ainscow Ash K. Bahl David Carling Matthew J. Fuchter Simak Ali Charlotte L. Be Source Type: research